LYKALABS logo

LYKA LABS LTD.

LYKALABS·NSE·
73.00 -0.86 (-1.16%)
Market Cap267.02 Cr
PE Ratio-28.10
Volume623
Day High - Low73.00 - 73.00
52W High-Low102.55 - 44.10
DocStoX Score
3.0/10
Poor
Fair Value
Sign in to see
ROE
-10.20%
Weak
P/E
-28.10x
Loss-making
Debt / Equity
0.56
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

52W44.10
102.55
DocStoX take

Held back by quality (1.0).

DocStoX score

Low confidence
3.0
/10
Poor
Quality
Weak
ROE -10.2%
Valuation
Fair
P/B 2.8× on assets (no earnings to value)
Growth
Slow
Revenue +8.3% 5Y CAGR
Risk
Elevated
D/E 0.56
Momentum
Soft
49% of 52-week range

At a glance

Market Cap
₹267 Cr
52W High / Low
₹103 / ₹44
Dividend Yield
0.00%
Promoter Holding
58.45%
EPS (TTM)
₹-2.81
Book Value
₹25.90

Key highlights

  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

LYKA LABS LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.